June 4, 2014

Many cancer treatments are extraordinarily expensive. Some drugs can cost up to a hundred thousand dollars a year and those costs can go up as much as 15% annually. But, new research is taking a second look at profitable prescriptions, and whether increasing access to care may be better for health providers’ bottom lines in the long run. Chuck Coppola reports.

Additional Clips

  • Prince Harry Inherits Millions 9-15-17

    September 15, 2014

    Fred Weintraub, “Royal Watcher Extraordinaire” discusses Prince Harry’s princely inheritance.

  • Chart Talk 9-15-14

    September 15, 2014

    Alan Knuckman of Barchart Bulls-Eye Options offers a BP options play.

  • Making the Money Work 9-15-14

    September 15, 2014

    Deborah Fox of Fox College Funding offers insights on how to manage college tuition payments.

  • NFL Brands Backlash 9-15-14

    September 15, 2014

    Chuck Coppola investigates the big name brands who may be saying bye-bye to NFL sponsorship.

  • Trader Talk 9-15-14

    September 15, 2014

    Mark Sebastian of Option Pit Mentoring looks into the possibility of an EBAY/GOOG merge..

  • 9-15-2014 FULL EPISODE

    September 15, 2014

    Financial news, analysis, and today’s investment ideas.

  • Middle Market Muscle 9-12-14

    September 12, 2014

    Mid-market companies are about to get a boost from investors. Bill Moller has the story.

  • Chart Talk 9-12-14

    September 12, 2014

    Scott Bauer of Trading Advantage is watching the moves in LULU stock.

  • Trader Talk 9-12-14

    September 12, 2014

    Bob Iaccino of Tethys Partners is looking at dips in CL and WTI.

  • More Foreclosures 9-12-14

    September 12, 2014

    Chuck Coppola reports on why foreclosures are up, but it’s no cause for alarm.